article thumbnail

Biden to propose expanding Medicare drug price negotiation in State of the Union

STAT

WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug price negotiation program and will preview the plan in his State of the Union address, the White House announced Wednesday.

article thumbnail

STAT+: Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation

STAT

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program. Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices

STAT

WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the CEOs of Johnson & Johnson and Merck related to an investigation into high drug prices in the United States, he announced Thursday. Read the rest…

article thumbnail

STAT+: Judge skeptical of arguments against Medicare drug price negotiation

STAT

— Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. WILMINGTON, Del. It didn’t go well for them.

article thumbnail

Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says

STAT

Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional staff that he didn’t have the expertise to testify at a Senate hearing on prescription drug prices because he’s a tax attorney.

article thumbnail

Medicare drug price negotiation’s day in court

STAT

So my enterprising colleague John Wilkerson trekked up to Wilmington to give you an inside view on how a key judge viewed arguments in the first court test of the new Medicare drug price negotiation program. Read the rest…

article thumbnail

STAT+: Biden administration makes opening offers in Medicare drug price negotiations

STAT

WASHINGTON  — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.